Picture of Sutro Biopharma logo

STRO — Sutro Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Sutro Biopharma Gets Notice Of Termination From Celgene Of Amended, Restated Collaboration, License Agreement

June 14 (Reuters) - Sutro Biopharma Inc  STRO.O :
    * SUTRO BIOPHARMA INC -  ON JUNE 9, GOT NOTICE OF
TERMINATION FROM
CELGENE CORPORATION OF AMENDED AND RESTATED COLLABORATION AND
LICENSE AGREEMENT
    * SUTRO BIOPHARMA INC - TERMINATION OF AGREEMENT IS
EFFECTIVE AS
OF OCTOBER 7, 2023
    * SUTRO BIOPHARMA INC - FROM AND AFTER TERMINATION DATE,
COMPANY
WILL HAVE SOLE WORLDWIDE RIGHTS TO CC-99712

Further company coverage:  STRO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sutro Biopharma

See all news